Moreover, a meta-analysis examining the efficacy of statins in treating fatty liver disease and steatohepatitis revealed that statin use significantly reduced aspartate transaminase (AST) and alanine transaminase (ALT) levels, along with notable improvements in liver histology among patients with fatty liver disease across various clinical trials [159], particularly in those with concomitant hyperlipidemia [160]. Here, GPT is linked to fatty liver disease.